BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21152397)

  • 21. Differential activation of nitric-oxide synthase isozymes by calmodulin-troponin C chimeras.
    Newman E; Spratt DE; Mosher J; Cheyne B; Montgomery HJ; Wilson DL; Weinberg JB; Smith SM; Salerno JC; Ghosh DK; Guillemette JG
    J Biol Chem; 2004 Aug; 279(32):33547-57. PubMed ID: 15138276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor-regulated dynamic interaction between endothelial nitric oxide synthase and calmodulin revealed by fluorescence resonance energy transfer in living cells.
    Jobin CM; Chen H; Lin AJ; Yacono PW; Igarashi J; Michel T; Golan DE
    Biochemistry; 2003 Oct; 42(40):11716-25. PubMed ID: 14529282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained endothelial nitric-oxide synthase activation requires capacitative Ca2+ entry.
    Lin S; Fagan KA; Li KX; Shaul PW; Cooper DM; Rodman DM
    J Biol Chem; 2000 Jun; 275(24):17979-85. PubMed ID: 10849433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High glutathionylation of placental endothelial nitric oxide synthase in preeclampsia.
    Guerby P; Swiader A; Augé N; Parant O; Vayssière C; Uchida K; Salvayre R; Negre-Salvayre A
    Redox Biol; 2019 Apr; 22():101126. PubMed ID: 30738311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.
    Wohlfart P; Xu H; Endlich A; Habermeier A; Closs EI; Hübschle T; Mang C; Strobel H; Suzuki T; Kleinert H; Förstermann U; Ruetten H; Li H
    J Pharmacol Exp Ther; 2008 May; 325(2):370-9. PubMed ID: 18252813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cysteine-674 of the sarco/endoplasmic reticulum calcium ATPase is required for the inhibition of cell migration by nitric oxide.
    Ying J; Tong X; Pimentel DR; Weisbrod RM; Trucillo MP; Adachi T; Cohen RA
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):783-90. PubMed ID: 17234728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PABA/NO as an anticancer lead: analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity.
    Saavedra JE; Srinivasan A; Buzard GS; Davies KM; Waterhouse DJ; Inami K; Wilde TC; Citro ML; Cuellar M; Deschamps JR; Parrish D; Shami PJ; Findlay VJ; Townsend DM; Tew KD; Singh S; Jia L; Ji X; Keefer LK
    J Med Chem; 2006 Feb; 49(3):1157-64. PubMed ID: 16451080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Na(+)/H(+) exchanger inhibitor induces vasorelaxation through nitric oxide production in endothelial cells via intracellular acidification-associated Ca2(+) mobilization.
    Sasahara T; Yayama K; Matsuzaki T; Tsutsui M; Okamoto H
    Vascul Pharmacol; 2013 Apr; 58(4):319-25. PubMed ID: 23268360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
    Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
    J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrogen sulfide increases nitric oxide production with calcium-dependent activation of endothelial nitric oxide synthase in endothelial cells.
    Kida M; Sugiyama T; Yoshimoto T; Ogawa Y
    Eur J Pharm Sci; 2013 Jan; 48(1-2):211-5. PubMed ID: 23148920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S-glutathionylation uncouples eNOS and regulates its cellular and vascular function.
    Chen CA; Wang TY; Varadharaj S; Reyes LA; Hemann C; Talukder MA; Chen YR; Druhan LJ; Zweier JL
    Nature; 2010 Dec; 468(7327):1115-8. PubMed ID: 21179168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hsp90 ensures the transition from the early Ca2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells.
    Brouet A; Sonveaux P; Dessy C; Balligand JL; Feron O
    J Biol Chem; 2001 Aug; 276(35):32663-9. PubMed ID: 11425855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ginsenoside Rg3 increases nitric oxide production via increases in phosphorylation and expression of endothelial nitric oxide synthase: essential roles of estrogen receptor-dependent PI3-kinase and AMP-activated protein kinase.
    Hien TT; Kim ND; Pokharel YR; Oh SJ; Lee MY; Kang KW
    Toxicol Appl Pharmacol; 2010 Aug; 246(3):171-83. PubMed ID: 20546771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Signal transduction of eNOS activation.
    Fleming I; Busse R
    Cardiovasc Res; 1999 Aug; 43(3):532-41. PubMed ID: 10690325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial Nitric Oxide Synthase-Derived Nitric Oxide Prevents Dihydrofolate Reductase Degradation via Promoting S-Nitrosylation.
    Cai Z; Lu Q; Ding Y; Wang Q; Xiao L; Song P; Zou MH
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2366-73. PubMed ID: 26381869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S-nitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity.
    Ravi K; Brennan LA; Levic S; Ross PA; Black SM
    Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2619-24. PubMed ID: 14983058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179).
    Montagnani M; Chen H; Barr VA; Quon MJ
    J Biol Chem; 2001 Aug; 276(32):30392-8. PubMed ID: 11402048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.
    Gélinas DS; Bernatchez PN; Rollin S; Bazan NG; Sirois MG
    Br J Pharmacol; 2002 Dec; 137(7):1021-30. PubMed ID: 12429574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uric acid attenuates nitric oxide production by decreasing the interaction between endothelial nitric oxide synthase and calmodulin in human umbilical vein endothelial cells: a mechanism for uric acid-induced cardiovascular disease development.
    Park JH; Jin YM; Hwang S; Cho DH; Kang DH; Jo I
    Nitric Oxide; 2013 Aug; 32():36-42. PubMed ID: 23624269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of endothelial nitric oxide synthase: involvement of protein kinase G 1 beta, serine 116 phosphorylation and lipid structures.
    John TA; Ibe BO; Raj JU
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):148-58. PubMed ID: 17892503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.